Registro:

Referencias:

• Simpson, E.P., Mosier, D., Appel, S.H., Mechanisms of disease pathogenesis in amyotrophic lateral sclerosis. A central role for calcium (2002) Advances in Neurology, 88, pp. 1-19
• Strong, M.J., The basic aspects of therapeutics in amyotrophic lateral sclerosis (2003) Pharmacology and Therapeutics, 98 (3), pp. 379-414. , DOI 10.1016/S0163-7258(03)00040-8
• Nirmalananthan, N., Greensmith, L., Amyotrophic lateral sclerosis: Recent advances and future therapies (2005) Current Opinion in Neurology, 18 (6), pp. 712-729
• Lederer, C.W., Santama, N., Amyotrophic lateral sclerosis - The tools of the trait (2007) Biotechnology Journal, 2 (5), pp. 608-621. , DOI 10.1002/biot.200600247
• Siddique, T.H., Deng, X., Genetics of amyotrophic lateral sclerosis (1996) Human Molecular Genetics, 5, pp. 1465-1470
• Valdmanis, P.N., Daoud, H., Dion, P.A., Rouleau, G.A., Recent advances in the genetics of amyotrophic lateral sclerosis (2009) Current Neurology and Neuroscience Reports, 9 (3), pp. 198-205
• Baumann, J., Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids (1965) Acta Neurologica Scandinavica. Supplementum, 13, pp. 453-461
• Monstad, I., Dale, I., Petlund, C.F., Sjaastad, O., Plasma exchange in motor neuron disease. A controlled study (1979) Journal of Neurology, 221 (1), pp. 59-66. , DOI 10.1007/BF00313170
• Olarte, M.R., Schoenfeldt, R.S., McKiernan, G., Rowland, L.P., Plasmapheresis in amyotrophic lateral sclerosis (1980) Annals of Neurology, 8 (6), pp. 644-645
• Brown Jr., R.H., Hauser, S.L., Harrington, H., Weiner, H.L., Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis (1986) Archives of Neurology, 43 (4), pp. 383-384
• Appel, S.H., Stewart, S.S., Appel, V., Harati, Y., Mietlowski, W., Weiss, W., Belendiuk, G.W., A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis (1988) Archives of Neurology, 45 (4), pp. 381-386
• Drachman, D.B., Chaudhry, V., Cornblath, D., Kuncl, R.W., Pestronk, A., Clawson, L., Mellits, E.D., Order, S., Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation (1994) Annals of Neurology, 35 (2), pp. 142-150
• McGeer, E.G., McGeer, P.L., Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis (2005) BioDrugs, 19 (1), pp. 31-37. , DOI 10.2165/00063030-200519010-00004
• Engelhardt, J.I., Siklos, L., Komuves, L., Smith, R.G., Appel, S.H., Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons (1995) Synapse, 20 (3), pp. 185-199
• Siklos, L., Engelhardt, J., Harati, Y., Smith, R.G., Joo, F., Appel, S.H., Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis (1996) Annals of Neurology, 39 (2), pp. 203-216. , DOI 10.1002/ana.410390210
• Pullen, A.H., Humphreys, P., Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls (2000) Journal of the Neurological Sciences, 180 (1-2), pp. 35-45
• Pullen, A.H., Demestre, M., Howard, R.S., Orrell, R.W., Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement (2004) Acta Neuropathologica, 107 (1), pp. 35-46. , DOI 10.1007/s00401-003-0777-z
• Pagani, M.R., Reisin, R.C., Uchitel, O.D., Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals (2006) Journal of Neuroscience, 26 (10), pp. 2661-2672. , http://www.jneurosci.org/cgi/reprint/26/10/2661, DOI 10.1523/JNEUROSCI.4394-05.2006
• Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., Pestronk, A., Coyle, J.T., Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (1990) Annals of Neurology, 28 (1), pp. 18-25. , DOI 10.1002/ana.410280106
• Rothstein, J.D., Martin, L.J., Kuncl, R.W., Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis (1992) New England Journal of Medicine, 326 (22), pp. 1464-1468
• Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J., Kuncl, R.W., Selective loss of glial glutamate transporter GLT-1 amyotrophic lateral sclerosis (1995) Annals of Neurology, 38 (1), pp. 73-84
• Cleveland, D.W., Rothstein, J.D., From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS (2001) Nature Reviews Neuroscience, 2 (11), pp. 806-819. , DOI 10.1038/35097565
• Van Den Bosch, L., Van Damme, P., Bogaert, E., Robberecht, W., The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis (2006) Biochimica et Biophysica Acta - Molecular Basis of Disease, 1762 (11-12), pp. 1068-1082. , DOI 10.1016/j.bbadis.2006.05.002, PII S0925443906000822
• Bowling, A.C., Schulz, J.B., Brown Jr., R.H., Beal, M.F., Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis (1993) Journal of Neurochemistry, 61 (6), pp. 2322-2325. , DOI 10.1111/j.1471-4159.1993.tb07478.x
• Bowling, A.C., Beal, M.F., Bioenergetic and oxidative stress in neurodegenerative diseases (1995) Life Sciences, 56 (14), pp. 1151-1171
• Liu, D., The roles of free radicals in amyotrophic lateral sclerosis (1996) Journal of Molecular Neuroscience, 7 (3), pp. 159-167
• Browne, S.E., Bowling, A.C., Baik, M.J., Gurney, M., Brown Jr., R.H., Beal, M.F., Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis (1998) Journal of Neurochemistry, 71 (1), pp. 281-287
• Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.L., Anderson, S.D., Ohama, E., Reaume, A.G., Cleveland, D.W., Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1 (1998) Science, 281 (5384), pp. 1851-1854. , DOI 10.1126/science.281.5384.1851
• Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Oda, T., TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2006) Biochemical and Biophysical Research Communications, 351 (3), pp. 602-611. , DOI 10.1016/j.bbrc.2006.10.093, PII S0006291X06023187
• Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Lee, V.M.-Y., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2006) Science, 314 (5796), pp. 130-133. , DOI 10.1126/science.1134108
• Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Shaw, C.E., TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis (2008) Science, 319 (5870), pp. 1668-1672. , DOI 10.1126/science.1154584
• Beal, M.F., Mitochondrial dysfunction in neurodegenerative diseases (1998) Biochimica et Biophysica Acta - Bioenergetics, 1366 (1-2), pp. 211-223. , DOI 10.1016/S0005-2728(98)00114-5, PII S0005272898001145
• Orth, M., Schapira, A.H.V., Mitochondria and degenerative disorders (2001) American Journal of Medical Genetics - Seminars in Medical Genetics, 106 (1), pp. 27-36. , DOI 10.1002/ajmg.1425
• Uchitel, O.D., Appel, S.H., Crawford, F., Sczcupak, L., Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals (1988) Proceedings of the National Academy of Sciences of the United States of America, 85 (19), pp. 7371-7374
• Uchitel, O.D., Scornik, F., Protti, D.A., Fumberg, C.G., Alvarez, V., Appel, S.H., Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins (1992) Neurology, 42 (11), pp. 2175-2180
• Appel, S.H., Smith, R.G., Engelhardt, J.I., Stefani, E., Evidence for autoimmunity in amyotrophic lateral sclerosis (1994) Journal of TheNeurological Sciences, 124, pp. S14-S19
• Fratantoni, S.A., Dubrovsky, A.L., Uchitel, O.D., Uptake of immunoglobulin G from amyotrophic lateral sclerosis patients by motor nerve terminals in mice (1996) Journal of the Neurological Sciences, 137 (2), pp. 97-102. , DOI 10.1016/0022-510X(95)00345-3
• Fratantoni, S.A., Weisz, G., Pardal, A.M., Reisin, R.C., Uchitel, O.D., Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker (2000) Muscle and Nerve, 23 (4), pp. 543-550. , DOI 10.1002/(SICI)1097-4598(200004)23:4<543::AID-MUS13>3.0.CO;2-S
• Antel, J.P., Arnason, B.G., Fuller, T.C., Lehrich, J.R., Histocompatibility typing in amyotrophic lateral sclerosis (1976) Archives of Neurology, 33 (6), pp. 423-425
• Oldstone, M.B., Wilson, C.B., Perrin, L.H., Norris Jr., F.H., Evidence for immune-complex formation in patients with amyotrophic lateral sclerosis (1976) Lancet, 2 (7978), pp. 169-172
• Appel, S.H., Stockton-Appel, V., Stewart, S.S., Kerman, R.H., Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations (1986) Archives of Neurology, 43 (3), pp. 234-238
• Field, E.J., Hughes, D., Toxicity of motor neurone disease serum for myelin in tissue culture (1965) British Medical Journal, 5475, pp. 1399-1401
• Roisen, F.J., Bartfeld, H., Donnenfeld, H., Baxter, J., Neuron specific in vitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis (1982) Muscle and Nerve, 5 (1), pp. 48-53
• Smith, R.G., Alexianu, M.E., Crawford, G., Nyormoi, O., Stefanii, E., Appel, S.H., Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line (1994) Proceedings of the National Academy of Sciences of the United States of America, 91 (8), pp. 3393-3397
• Horwich, M.S., Engel, W.K., Chauvin, P.B., Amyotrophic lateral sclerosis sera applied to cultured motor neurons (1974) Archives of Neurology, 30 (4), pp. 332-333
• Mather, J.P., Roberts, P.E., (1998) Introduction to Cell and Tissue Culture: Theory and Technique, , Plenum Press, San Francisco, Calif, USA
• Lisak, R.P., Zwiman, B., Norman, M., Antimyelin antibodies in neurologic diseases. Immunofluorescent demonstration (1975) Archives of Neurology, 32 (3), pp. 163-167
• Liveson, J., Frey, H., Bornstein, M.B., The effect of serum from ALS patients on organotypic nerve and muscle tissue cultures (1975) Acta Neuropathologica, 32 (2), pp. 127-131
• Li, B., Liu, X.-Y., Li, Z., Bu, H., Sun, M.-M., Guo, Y.-S., Li, C.-Y., Effect of ALS IgG on motor neurons in organotypic spinal cord cultures (2008) Canadian Journal of Neurological Sciences, 35 (2), pp. 220-225
• Mulder, D.W., Lambert, E.H., Eaton, L.M., Myasthenic syndrome in patients with amyotrophic lateral sclerosis (1959) Neurology, 9, pp. 627-631
• Denys, E.H., Norris Jr., F.H., Amyotrophic lateral sclerosis. Impairment of neuromuscular transmission (1979) Archives of Neurology, 36 (4), pp. 202-205
• Maselli, R.A., Wollman, R.L., Leung, C., Distad, B., Palombi, S., Richman, D.P., Salazar-Grueso, E.F., Roos, R.P., Neuromuscular transmission in amyotrophic lateral sclerosis (1993) Muscle and Nerve, 16 (11), pp. 1193-1203. , DOI 10.1002/mus.880161109
• Yoshihara, T., Ishii, T., Iwata, M., Nomoto, M., Ultrastructural and histochemical study of the motor end plates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis (1998) Ultrastructural Pathology, 22 (2), pp. 121-126
• Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Glass, J.D., Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man (2004) Experimental Neurology, 185 (2), pp. 232-240. , DOI 10.1016/j.expneurol.2003.10.004
• Appel, S.H., Engelhardt, J.I., Garcá, J., Stefani, E., Autoimmunity and ALS: A comparison of animal models of immune-mediated motor neuron destruction and human ALS (1991) Advances in Neurology, 56, pp. 405-412
• O'Shaughnessy, T.J., Yan, H., Kim, J., Middlekauff, E.H., Lee, K.W., Phillips, L.H., Kim, J., Kim, Y.I., Amyotrophic lateral sclerosis: Serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction (1998) Muscle and Nerve, 21 (1), pp. 81-90. , DOI 10.1002/(SICI)1097-4598(199801)21:1<81::AID-MUS11>3.0.CO;2-3
• Mohamed, H.A., Mosier, D.R., Zou, L.L., Siklos, L., Alexianu, M.E., Engelhardt, J.I., Beers, D.R., Appel, S.H., Immunoglobulin Fcγ receptor promotes immunoglobulin uptake, immunoglobulin-mediated Calcium increase, and neurotransmitter release in motor neurons (2002) Journal of Neuroscience Research, 69 (1), pp. 110-116. , DOI 10.1002/jnr.10271
• Muchnik, S., Losavio, A., Lorenzo, S.D., Effect of amyotrophic lateral sclerosis serum on calcium channels related to spontaneous acetylcholine release (2002) Clinical Neurophysiology, 113 (7), pp. 1066-1071. , DOI 10.1016/S1388-2457(02)00108-6, PII S1388245702001086
• Bernstein, L.P., Antel, J.P., Motor neuron disease: Decremental responses to repetitive nerve stimulation (1981) Neurology, 31 (2), pp. 204-207
• Sharma, K.R., Kent-Braun, J.A., Majumdar, S., Physiology of fatigue in amyotrophic lateral sclerosis (1995) Neurology, 45 (4), pp. 733-740
• Protti, D.A., Reisin, R., Mackinley, T.A., Uchitel, O.D., Calcium channel blockers and transmitter release at the normal human neuromuscular junction (1996) Neurology, 46 (5), pp. 1391-1396
• Katz, E., Ferro, P.A., Weisz, G., Uchitel, O.D., Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction (1996) Journal of Physiology, 497 (3), pp. 687-697
• Pagani, R., Song, M., Mcenery, M., Qin, N., Tsien, R.W., Toro, L., Stefani, E., Uchitel, O.D., Differential expression of α1 and β subunits of voltage dependent Ca2+ channel at the neuromuscular junction of normal and P/Q Ca2+ channel knockout mouse (2004) Neuroscience, 123 (1), pp. 75-85. , DOI 10.1016/j.neuroscience.2003.09.019
• Sugiura, Y., Ko, C.-P., Novel modulatory effect of L-type calcium channels at newly formed neuromuscular junctions (1997) Journal of Neuroscience, 17 (3), pp. 1101-1111
• Rosato Siri, M.D., Uchitel, O.D., Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions (1999) Journal of Physiology, 514 (2), pp. 533-540. , DOI 10.1111/j.1469-7793.1999.533ae.x
• Santafé, M.M., Urbano, F.J., Lanuza, M.A., Uchitel, O.D., Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mousemotor nerve terminals (2000) Neuroscience, 95 (1), pp. 227-234
• Engelhardt, J.I., Appel, S.H., Killian, J.M., Experimental autoimmune motoneuron disease (1989) Annals of Neurology, 26 (3), pp. 368-376
• Engelhardt, J.I., Appel, S.H., IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis (1990) Archives of Neurology, 47 (11), pp. 1210-1216
• Engelhardt, J.I., Soos, J., Obal, I., Vigh, L., Siklos, L., Subcellular localization of IgG from the sera of ALS patients in the nervous system (2005) Acta Neurologica Scandinavica, 112 (2), pp. 126-133. , DOI 10.1111/j.1600-0404.2005.00445.x
• Price, D.L., Griffin, J., Young, A., Peck, K., Stocks, A., Tetanus toxin: Direct evidence for retrograde intraaxonal transport (1975) Science, 188 (4191), pp. 945-947
• Joseph, K.C., Kim, S.U., Stieber, A., Gonatas, N.K., Endocytosis of cholera toxin into neuronal GERL (1978) Proceedings of the National Academy of Sciences of the United States of America, 75 (6), pp. 2815-2819
• Fabian, R.H., Uptake of plasma IgG by CNS motoneurons: Comparison of antineuronal and normal IgG (1988) Neurology, 38 (11), pp. 1775-1780
• Arvidson, B., Accumulation of inorganic mercury in lower motoneurons of mice (1992) NeuroToxicology, 13 (1), pp. 277-280
• Demestre, M., Pullen, A., Orrell, R.W., Orth, M., ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures (2005) Journal of Neurochemistry, 94 (1), pp. 268-275. , DOI 10.1111/j.1471-4159.2005.03184.x
• Alexianu, M.E., Ho, B.-K., Mohamed, A.H., La Bella, V., Smith, R.G., Appel, S.H., The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis (1994) Annals of Neurology, 36 (6), pp. 846-858. , DOI 10.1002/ana.410360608
• Yi, F.H., Lautrette, C., Vermot-Desroches, C., In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients (2000) Journal of Neuroimmunology, 109 (2), pp. 211-220
• Parkes, A.B., Rickards, C.R., Rees, P., Scanlon, M.F., Cytotoxic changes in A172 glioblastoma cells exposed to serum Ig from patients with motor neurone disease (1995) Journal of the Neurological Sciences, 129, pp. S136-S137
• Delbono, O., Garcia, J., Appel, S.H., Stefani, E., Calcium current and charge movement of mammalian muscle: Action of amyotrophic lateral sclerosis immunoglobulins (1991) Journal of Physiology, 444, pp. 723-742
• Smith, R.G., Hamilton, S., Hofmann, F., Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis (1992) New England Journal of Medicine, 327 (24), pp. 1721-1728
• Kimura, F., Smith, R.G., Delbono, O., Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel ? Subunit (1994) Annals of Neurology, 35 (2), pp. 164-171
• Katz, B., Miledi, R., Further study of the role of calcium in synaptic transmission (1970) Journal of Physiology, 207 (3), pp. 789-801
• Augustine, G.J., Charlton, M.P., Smith, S.J., Calcium action in synaptic transmitter release (1987) Annual Review of Neuroscience, 10, pp. 633-693
• Miller, R.G., Smith, S.A., Murphy, J.R., Brinkmann, J.R., Graves, J., Mendoza, M., Sands, M.L., Ringel, S.P., A clinical trial of verapamil in amyotrophic lateral sclerosis (1996) Muscle and Nerve, 19 (4), pp. 511-515. , DOI 10.1002/mus.880190405
• Miller, R.G., Shepherd, R., Dao, H., Khramstov, A., Mendoza, M., Graves, J., Smith, S., Controlled trial of nimodipine in amyotrophic lateral sclerosis (1996) Neuromuscular Disorders, 6 (2), pp. 101-104. , DOI 10.1016/0960-8966(95)00024-0
• Uchitel, O.D., Protti, D.A., Sanchez, V., Cherksey, B.D., Sugimori, M., Llinas, R., P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses (1992) Proceedings of the National Academy of Sciences of the United States of America, 89 (8), pp. 3330-3333
• Protti, D.A., Szczupak, L., Scornik, F.S., Uchitel, O.D., Effect of conotoxin GVIA on neurotransmitter release at themouse neuromuscular junction (1991) Brain Research, 557 (1-2), pp. 336-339
• Katz, E., Ferro, P.A., Cherksey, B.D., Sugimori, M., Llinás, R., Uchitel, O.D., Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction (1995) Journal of Physiology, 486 (3), pp. 695-706
• Perissinotti, P.P., Tropper, B.G., Uchitel, O.D., L-type calcium channels are involved in fast endocytosis at the mouse neuromuscular junction (2008) European Journal of Neuroscience, 27 (6), pp. 1333-1344. , DOI 10.1111/j.1460-9568.2008.06113.x
• Nyormoi, O., Proteolytic activity in amyotrophic lateral sclerosis IgG preparations (1996) Annals of Neurology, 40 (5), pp. 701-706
• Demestre, M., Howard, R.S., Orrell, R.W., Pullen, A.H., Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgG (2006) Neuropathology and Applied Neurobiology, 32 (2), pp. 141-156
• Llinas, R., Sugimori, M., Cherksey, B.D., Smith, R.G., Delbono, O., Stefani, E., Appel, S., IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer (1993) Proceedings of the National Academy of Sciences of the United States of America, 90 (24), pp. 11743-11747. , DOI 10.1073/pnas.90.24.11743
• Zhainazarov, A.B., Annunziata, P., Toneatto, S., Cherubini, E., Nistri, A., Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ currents of rat cerebellar granule cells in culture (1994) Neuroscience Letters, 172 (1-2), pp. 111-114
• Carter, J.R., Mynlieff, M., Amyotrophic lateral sclerosis patient IgG alters voltage dependence of Ca2+ channels in dissociated rat motoneurons (2003) Neuroscience Letters, 353 (3), pp. 221-225. , DOI 10.1016/j.neulet.2003.09.036
• Mosier, D.R., Baldelli, P., Delbono, O., Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line (1995) Annals of Neurology, 37 (1), pp. 102-109
• Dun Yan, H., Lim, W., Woo Lee, K., Kim, J., Sera from amyotrophic lateral sclerosis patients reduce high-voltage activated Ca2+ currents in mice dorsal root ganglion neurons (1997) Neuroscience Letters, 235 (1-2), pp. 69-72. , DOI 10.1016/S0304-3940(97)00720-9, PII S0304394097007209
• Catterall, W.A., Structure and regulation of voltage-gated Ca2+ channels (2000) Annual Review of Cell and Developmental Biology, 16, pp. 521-555. , DOI 10.1146/annurev.cellbio.16.1.521
• Fitzgerald, E.M., Regulation of rat neuronal voltage-dependent calcium channels by endogenous p21-ras (1997) European Journal of Neuroscience, 9 (6), pp. 1252-1261. , DOI 10.1111/j.1460-9568.1997.tb01480.x
• Martin, S.W., Butcher, A.J., Berrow, N.S., Richards, M.W., Paddon, R.E., Turner, D.J., Dolphin, A.C., Fitzgerald, E.M., Phosphorylation sites on calcium channel α1 and β subunits regulate ERK-dependent modulation of neuronal N-type calcium channels (2006) Cell Calcium, 39 (3), pp. 275-292. , DOI 10.1016/j.ceca.2005.11.002, PII S0143416005002150
• Drachman, D.B., Fishman, P.S., Rothstein, J.D., Amyotrophic lateral sclerosis. An autoimmune disease? (1995) Advances in Neurology, 68, pp. 59-65
• Arsac, C., Raymond, C., Martin-Moutot, N., Dargent, B., Couraud, F., Pouget, J., Seagar, M., Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum (1996) Annals of Neurology, 40 (5), pp. 695-700
• Pestronk, A., Adams, R.N., Clawson, L., Serum antibodies to GM ganglioside in amyotrophic lateral sclerosis (1988) Neurology, 38 (9), pp. 1457-1461
• Ordonez, G., Sotelo, J., Antibodies against fetal muscle proteins in serum from patients with amyotrophic lateral sclerosis (1989) Neurology, 39 (5), pp. 683-686
• Greiner, A., Marx, A., Muller-Hermelink, K.H., Schmausser, B., Petzold, K., Kruger, H., Vascular autoantibodies in amyotrophic lateral sclerosis (1992) Lancet, 340 (8815), pp. 378-379
• Couratier, P., Yi, F.-H., Preud'Homme, J.-L., Clavelou, P., White, A., Sindou, P., Vallat, J.-M., Jauberteau, M.-O., Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis (1998) Journal of the Neurological Sciences, 154 (2), pp. 137-145. , DOI 10.1016/S0022-510X(97)00219-0, PII S0022510X97002190
• Niebroj-Dobosz, I., Dziewulska, D., Janik, P., Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS) (2006) Folia Neuropathologica, 44 (3), pp. 191-196
• Fialová, L., Svarcová, J., Bartos, A., Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis (2010) European Journal of Neurology, 17 (4), pp. 562-566
• Raoul, C., Estevez, A.G., Nishimune, H., Cleveland, D.W., DeLapeyriere, O., Henderson, C.E., Haase, G., Pettmann, B., Motoneuron death triggered by a specific pathway downstream of fas: Potentiation by ALS-linked SOD1 mutations (2002) Neuron, 35 (6), pp. 1067-1083. , DOI 10.1016/S0896-6273(02)00905-4
• Xiong, Z.-Q., McNamara, J.O., Fas(t) balls and Lou Gehrig disease: A clue to selective vulnerability of motor neurons? (2002) Neuron, 35 (6), pp. 1011-1013. , DOI 10.1016/S0896-6273(02)00910-8
• Naor, S., Keren, Z., Bronshtein, T., Goren, E., Machluf, M., Melamed, D., Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes (2009) Journal of Neurology, 256 (8), pp. 1228-1235
• Tuzun, E., Dalmau, J., Limbic encephalitis and variants: Classification, diagnosis and treatment (2007) Neurologist, 13 (5), pp. 261-271. , DOI 10.1097/NRL.0b013e31813e34a5, PII 0012789320070900000003
• Orrenius, S., Zhivotovsky, B., Nicotera, P., Regulation of cell death: The calcium-apoptosis link (2003) Nature Reviews Molecular Cell Biology, 4 (7), pp. 552-565. , DOI 10.1038/nrm1150
• Thomas, M.M., Dunn, S.M.J., Amyotrophic lateral sclerosis immunoglobulins are ineffective in altering calcium influx through presynaptic voltage-sensitive calcium channels (1997) Neurological Research, 19 (2), pp. 129-134
• Xu, L., Guo, Y.S., Liu, Y.L., Oxidative stress in immunemediated motoneuron destruction (2009) Brain Research, 1302, pp. 225-232
• Troost, D., Van Den Oord, J.J., De Jong, J.M.B.V., Swaab, D.F., Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis (1989) Clinical Neuropathology, 8 (6), pp. 289-294
• Troost, D., Claessen, N., Van Den Oord, J.J., Swaab, D.F., De Jong, J.M.B.V., Neuronophagia in the motor cortex in amyotrophic lateral sclerosis (1993) Neuropathology and Applied Neurobiology, 19 (5), pp. 390-397
• Bartfeld, H., Dham, C., Donnenfeld, H., Immunoregulatory and activated T cells in amyotrophic lateral sclerosis patients (1985) Journal of Neuroimmunology, 9 (3-4), pp. 131-137
• Behan, W.M.H., Behan, P.O., Recent advances in polymyositis (1984) Italian Journal of Neurological Sciences, 5 (1), pp. 23-31
• Troost, D., Van Den Oord, J.J., Vianney De Jong, J.M., Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis (1990) Neuropathology and Applied Neurobiology, 16 (5), pp. 401-410
• Engelhardt, J.I., Tajti, J., Appel, S.H., Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis (1993) Archives of Neurology, 50 (1), pp. 30-36
• Graves, M.C., Fiala, M., Dinglasan, L.A.V., Liu, N.Q., Sayre, J., Chiappelli, F., Van Kooten, C., Vinters, H.V., Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and t cells (2004) Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5 (4), pp. 213-219. , DOI 10.1080/14660820410020286
• Rentzos, M., Rombos, A., Nikolaou, C., Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: A reflection of Th17 cells activation? (2010) Acta Neurologica Scandinavica, 122 (6), pp. 425-429
• Henkel, J.S., Engelhardt, J.I., Siklos, L., Simpson, E.P., Kim, S.H., Pan, T., Goodman, J.C., Appel, S.H., Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue (2004) Annals of Neurology, 55 (2), pp. 221-235. , DOI 10.1002/ana.10805
• Henkel, J.S., Beers, D.R., Siklos, L., Appel, S.H., The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS (2006) Molecular and Cellular Neuroscience, 31 (3), pp. 427-437. , DOI 10.1016/j.mcn.2005.10.016, PII S1044743105002563
• Alexianu, M.E., Kozovska, M., Appel, S.H., Immune reactivity in a mouse model of familial ALS correlates with disease progression (2001) Neurology, 57 (7), pp. 1282-1289
• Kornberg, A.J., Pestronk, A., Chronic motor neuropathies: Diagnosis, therapy, and pathogenesis (1995) Annals of Neurology, 37 (1), pp. S43-S50
• Roberts, M., Willison, H.J., Vincent, A., Newsom-Davis, J., Multifocal motor neuropathy human sera block distal motor nerve conduction in mice (1995) Annals of Neurology, 38 (1), pp. 111-118
• Newsom-Davis, J., High hopes .. for neurology. A view from the top (1994) Journal of the Royal College of Physicians of London, 28 (2), p. 105
• Swash, M., We have a problem: Why have ALS trials been negative? (2007) Amyotrophic Lateral Sclerosis, 8 (5), p. 259. , DOI 10.1080/17482960701649887, PII 782650638
• Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M.L., Lazzeri, G., Paparelli, A., Lithium delays progression of amyotrophic lateral sclerosis (2008) Proceedings of the National Academy of Sciences of the United States of America, 105 (6), pp. 2052-2057. , http://www.pnas.org/cgi/reprint/105/6/2052, DOI 10.1073/pnas.0708022105
• Meininger, V., Shefner, J., Cudkowicz, M., Lithium therapy in ALS (2008) Amyotrophic Lateral Sclerosis, 9 (2), p. 122. , DOI 10.1080/17482960802028247, PII 792341905
• Bedlack, R.S., Maragakis, N., Heiman-Patterson, T., Lithium may slow progression of amyotrophic lateral sclerosis, but further study is needed (2008) Proceedings of the National Academy of Sciences of the United States of America, 105 (16), pp. E17. , http://www.pnas.org/cgi/reprint/105/16/E17, DOI 10.1073/pnas.0801762105
• Gill, A., Kidd, J., Vieira, F., Thompson, K., Perrin, S., No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS (2009) PLoS ONE, 4 (8). , Article ID e6489
• Smith, R.G., Appel, S.H., Immunosuppression and antiinflammatory agents in ALS (2000) Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1 (SUPPL.4), pp. 33-43
• Rossini, A.A., Autoimmune diabetes and the circle of tolerance (2004) Diabetes, 53 (2), pp. 267-275. , DOI 10.2337/diabetes.53.2.267
• Dib, M., Amyotrophic lateral sclerosis: Progress and prospects for treatment (2003) Drugs, 63 (3), pp. 289-310. , DOI 10.2165/00003495-200363030-00004
• Cudkowicz, M.E., Shefner, J.M., Schoenfeld, D.A., Trial of celecoxib in amyotrophic lateral sclerosis (2006) Annals of Neurology, 60 (1), pp. 22-31
• Brooks, B.R., El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis (1994) Journal of the Neurological Sciences, 124, pp. 96-107. , Subcommittee onMotor Neuron Diseases/Amyotrophic Lateral Sclerosis of theWorld Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial, Clinical limits of amyotrophic lateral sclerosis. workshop contributors
• Ekbom, K., The man behind the syndrome: Jean-Martin Charcot (1992) Journal of the History of the Neurosciences, 1 (1), pp. 39-45
• Ince, P.G., Slade, J., Chinnery, R.M., Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord inmotor neuron disease (1995) Journal of Neuropathology and Experimental Neurology, 54 (5), pp. 673-679
• Cwik, V.A., Hanstock, C.C., Allen, P.S., Wayne Martin, W.R., Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy (1998) Neurology, 50 (1), pp. 72-77
• Arasaki, K., Kato, Y., Hyodo, A., Ushijima, R., Tamaki, M., Longitudinal study of functional spinal alpha motor neuron loss in amyotrophic lateral sclerosis (2002) Muscle and Nerve, 25 (4), pp. 520-526. , DOI 10.1002/mus.10067
• Vincent, A., Immunology of the neuromuscular junction and presynaptic nerve terminal (1999) Current Opinion in Neurology, 12 (5), pp. 545-551. , DOI 10.1097/00019052-199910000-00008
• Shefner, J.M., Reaume, A.G., Flood, D.G., Scott, R.W., Kowall, N.W., Ferrante, R.J., Siwek, D.F., Brown Jr., R.H., Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy (1999) Neurology, 53 (6), pp. 1239-1246
• Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V., Lacomis, D., Urbinelli, L., Newhall, K., Bowser, R., Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis (2005) Journal of Neurochemistry, 95 (5), pp. 1461-1471. , DOI 10.1111/j.1471-4159.2005.03478.x
• Bowser, R., Cudkowicz, M., Kaddurah-Daouk, R., Biomarkers for amyotrophic lateral sclerosis (2006) Expert Review of Molecular Diagnostics, 6 (3), pp. 387-398. , http://www.future-drugs.com/doi/pdf/10.1586/14737159.6.3.387, DOI 10.1586/14737159.6.3.387
• McCawley, L.J., Matrisian, L.M., Matrix metalloproteinases: They're not just for matrix anymore! (2001) Current Opinion in Cell Biology, 13 (5), pp. 534-540. , DOI 10.1016/S0955-0674(00)00248-9
• Demestre, M., Parkin-Smith, G., Petzold, A., Pullen, A.H., The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis (2005) Journal of Neuroimmunology, 159 (1-2), pp. 146-154. , DOI 10.1016/j.jneuroim.2004.09.015, PII S016557280400356X
• Fang, L., Teuchert, M., Huber-Abel, F., MMP-2 and MMP-9 are elevated in spinal cord and skin in amouse model of ALS (2010) Journal of the Neurological Sciences, 294 (1-2), pp. 51-56
• Gwinn, K., Corriveau, R.A., Mitsumoto, H., Amyotrophic lateral sclerosis: An emerging era of collaboratie gene discovery (2007) PLoS ONE, 2 (12). , Article ID e1254

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------